08.09.2022; Vortragsreihe
CMCB Life Sciences Seminar: Hilmar Bading, University of Heidelberg
Zeit
13:00
-
14:00
Uhr
Ort
CRTD, Auditorium
Title: „NMDAR/TRPM4 interface inhibitors: new pharmacological principle for treatment of human neurodegenerative diseases“
Host: Tomohisa Toda (DZNE)